A 2-day workshop programme to commemorate the start-up of the RSSH-II grant took place on the 24th and 25th June, 2021 at 3J’s hotel, Utako, Abuja.

The Global fund of the RSSH-II grant, a major funder of the Nigeria health systems has been saddled with the mandate to support middle income countries in Africa. They have been investing US$1 billion a year to build resilient and sustainable system for health. This includes: improving procurement and supply chains; strengthening data systems and data use; building an adequate health workforce; strengthening community responses and systems; and promoting more integrated service delivery so the universal health coverage can be a reality.

Global Fund investments are also helping countries improve their supply chain management, including commodity planning, logistics management, warehousing and information tracking.

The commencement of the RSSH-II grant is about to start-up that spans over a period of three (3) years. There is need to incorporate the overall mandate and vision of the GF into the principal recipient’s and Sub-recipient’s mode of operation in their interventions in proffering solution of any identified areas of concern across the health section in Nigeria.

The Principal recipient of this RSSH grant is NACA (National Agencies for the Control of Aids) and four Sub-recipients are:

  • National Product Supply Chain Management Programme (NPSCMP)
  • National Primary Health Care Development Agency (NPHCDA)
  • Nigeria Centre for Disease Control (NCDC)
  • Department of Planning and Research Statistics (DPRS).

Goals and Objectives discussed in the workshop include:

  • To highlight key strategies that will lead to grant success.
  • To discuss monthly performance tracking tool
  • To describe the expected channels of communication and efficient communication flow between the different entities; PR, SR, GFA, and CT
  • To provide details of procurement process from planning phase to implementation.
  • To provide clarify expectations
  • Discuss sustainability planning and disease integration as key cross-cutting priorities.























Related posts